WHO to Evacuate 1,000 Gazan Women and Children for Urgent Medical Care
The WHO’s Europe branch is set to evacuate up to 1,000 Gazan women and children to Europe for urgent medical care, highlighting global humanitarian efforts.
WHO
Read More
Congo Begins First Mpox Vaccination Drive to Control Outbreak
Congo has launched its first mpox vaccination campaign to contain the outbreak affecting multiple African nations, addressing previous vaccine inequities.
Congo Initiates First Mpox Vaccination Campaign to Combat Outbreak
Congo has launched its first mpox vaccination campaign in Goma to tackle the outbreak spreading across African nations, addressing previous vaccine access inequities.
WHO’s First Emergency Mpox Test Approved, Boosting Global Health Response
WHO has approved the first emergency mpox diagnostic test, enhancing global efforts to detect and manage outbreaks.
Africa Battles Severe Mpox Outbreak with Nearly 30,000 Cases in 2024
WHO reports nearly 30,000 suspected mpox cases in Africa this year, with the DRC hardest hit. International aid is ramping up to control the outbreak.
WHO Approves First Mpox Vaccine for Global Use
The World Health Organization (WHO) has approved the MVA-BN vaccine as the first mpox vaccine on its prequalification list, enhancing global access and outbreak control efforts.
Africa CDC and WHO Unveil $600M Plan to Combat Rising Mpox Cases
Africa CDC and WHO launch a $600 million response plan to address the rising mpox cases across the continent, focusing on the DRC epicenter.
WHO Confirms Mpox Is Not a New COVID-19 Threat
WHO assures mpox is not the new COVID-19, emphasizing that existing control measures are effective in managing its spread globally.
DRC Declares Mpox Outbreak a Continental Emergency with Over 570 Deaths
DRC declares mpox outbreak a continental emergency with over 570 deaths and 16,700 cases, focusing on preventive measures and the arrival of vaccines next week.
WHO Declares Mpox a Global Health Emergency Amid Rising Cases
WHO declares mpox a public health emergency, highlighting rising cases and the risk of further spread. The EU and biotech firms are responding with vaccine donations.